NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks ofU. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.07% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.91% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.88% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.75% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.56% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.56% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 4.32% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.25% |
| OCUL | Ocular Therapeutix Inc | Healthcare | Biotechnology | 4.19% |
| AVDL | Avadel Pharmaceuticals PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.98% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.70% |
| ANIP | ANI Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.69% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.26% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 3.23% |
| LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 3.17% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.13% |
| AMRX | Amneal Pharmaceuticals, Inc. Class A Common Stock | Healthcare | Drug Manufacturers - Specialty & Generic | 3.11% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.92% |